Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
BNRE20210013BUndetermined Publication Date: 2022-01-31AMGEN INC
0 Cites 0 Cited by
Patent Information
- Application Number
- BNRE20210013
- Authority / Receiving Office
- BN · BN
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2011-06-03
- Filing Date
- 2021-11-01
- Publication Date
- 2022-01-31
- Estimated Expiration
- 2041-11-01
Need to check novelty before this filing date? Find Prior Art
No text content released.